XML 79 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
Collaborative Research, Development and License Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Oct. 31, 2021
May 31, 2021
Jan. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   $ 439,442 $ 46,551 $ 35,219      
Deferred revenue   55,400          
Coalition for Epidemic Preparedness Innovations              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Interest- free unsecured forgivable loan             $ 99,000
Advance payment from customer   168,500          
Accounts receivable $ 0 14,600 0        
CEPI accrual   128,800 0        
Valneva SE              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Advance payment from customer         $ 55,400    
Consideration Allocated To The Remaining Performance Obligation         $ 55,400    
U.S. Department of Defense              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   500          
Proceeds from grant   22,000          
Serum Institute of India Pvt. Ltd.              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   400 900 100      
Other Long Term Liabilities | Coalition for Epidemic Preparedness Innovations              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Advance payment from customer   5,400          
Reservation Agreement              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Interest- free unsecured forgivable loan           $ 77,400  
Reservation Agreement | Coalition for Epidemic Preparedness Innovations              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized 6,300            
Interest- free unsecured forgivable loan           $ 176,400  
Reservation fees 6,300            
Supply Agreement | Clover              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   72,200 0 0      
Deferred revenue 0 191,100 0        
Contract asset balance 0 62,500 0        
Accounts receivable 0 2,100 0        
Supply Agreement | Biological E. Limited              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   185,700 0 0      
Deferred revenue 0 103,300 0        
Accounts receivable 0 96,100 0        
Supply Agreement | Medigen              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   26,700 1,200 0      
Accounts receivable 0 2,400 0        
Supply Agreement | Valneva SE              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   89,400 2,000 $ 0      
Deferred revenue $ 37,000 55,400 $ 37,000        
Grant Agreement | Bill & Melinda Gates Foundation              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Revenue recognized   1,200          
Deferred revenue   1,200          
Amount Spend On Grant-related Activity   1,200          
Grant Agreement | Bill & Melinda Gates Foundation | Maximum              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Proceeds from grant   $ 3,400